Guardant Health (NASDAQ:GH) Receives “Overweight” Rating from Stephens
Stephens restated their overweight rating on shares of Guardant Health (NASDAQ:GH – Free Report) in a research report released on Wednesday,Benzinga reports. Stephens currently has a $55.00 price target on the stock. A number of other brokerages also recently issued reports on GH. Guggenheim reissued a “buy” rating and issued a $56.00 target price on […]
Stephens restated their overweight rating on shares of Guardant Health (NASDAQ:GH – Free Report) in a research report released on Wednesday,Benzinga reports. Stephens currently has a $55.00 price target on the stock. A number of other brokerages also recently issued reports on GH. Guggenheim reissued a “buy” rating and issued a $56.00 target price on […]
